Skip to main content
Equibles
PVLA $123.92 +0.78%
PVLA logo
PVLA · Palvella Therapeutics, Inc.
Track PVLA — free

Use PVLA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PVLA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$123.92 +0.96 (+0.78%)
Russell 2000 member Rebalance outlook locked
Market Cap
$1.77B
Shares
14.41M
Volume · Oct 20 263.35K Avg daily vol (3M) 208.37K
All webcasts

Earnings call · FY2020 Q2

Palvella Therapeutics, Inc. (PVLA) Q2 2020 Earnings Call

Concluded Aug 10, 2020
Aug 10, 2020 0 turns
Period
FY2020 Q2
Runtime
—
Sources
2 artifacts
Revenue $11.25M +110.9% YoY
Diluted EPS -$7.20
Net income -$4.95M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Aug 10, 2020 10-Q report Filed Aug 10, 2020

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Customer Revenue$10.93M +131.4% YoY
Collaboration Revenue$316,000 -48.1% YoY
Full-screen source Call document

PVLA alerts

Palvella Therapeutics, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →